Casdin Capital, LLC Iovance Biotherapeutics, Inc. Transaction History

Casdin Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $15.8 Million - $28.9 Million	-550,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $7.29 Million - $13.1 Million	260,000 Added 89.66%	550,000 $25.5 Million
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $8.05 Million - $10.5 Million	290,000 New	290,000 $9.55 Million

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.14B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.